freehire
/
Immunovant
Develops monoclonal antibody therapies for patients with autoimmune diseases.
Subscribe to updates
Discussion
Biotechnology
Pharmaceuticals
immunovant.com ↗
Company facts
Founded
2018
Employees
362
Headquarters
United States
Type
Public
Listed
NASDAQ: IMVT
Subsidiaries
IMVT Corporation